SDC:NSD-SmileDirectClub, Inc

| Medical Devices |

Last Closing

USD 10

Change

-0.31 (-3.01)%

Market Cap

USD 7.06B

Volume

4.74M

Analyst Target

USD 20.14
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-10-16 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
DXCM DexCom Inc

+0.44 (+0.33%)

USD 51.34B
ALGN Align Technology Inc

+1.20 (+0.40%)

USD 22.96B
BRKR Bruker Corporation

-4.38 (-5.28%)

USD 12.93B
PODD Insulet Corporation

-1.53 (-0.92%)

USD 11.49B
SWAV Shockwave Medical Inc

+0.02 (+0.01%)

USD 10.25B
MASI Masimo Corporation

-0.70 (-0.51%)

USD 7.14B
AXNX Axonics Modulation Technologie..

-0.15 (-0.22%)

USD 3.43B
IRTC iRhythm Technologies Inc

+0.63 (+0.57%)

USD 3.36B
QDEL Quidel Corporation

-0.45 (-1.16%)

USD 3.14B
LIVN LivaNova PLC

+0.89 (+1.72%)

USD 3.02B

ETFs Containing SDC

AIVI WisdomTree International .. 1.92 % 0.00 %

-0.14 (0.02%)

USD 0.07B
HAUD 0.00 % 0.03 %

N/A

N/A
CCON 0.00 % 0.00 %

N/A

N/A
AUESG:SW UBS (Irl) ETF plc - MSCI .. 0.00 % 0.00 %

+0.01 (+0.02%)

USD 0.09B

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A F
Risk Adjusted Return N/A N/A N/A N/A F
Market Capitalization 7.06B 96% N/A 92% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

What to not like:
Negative cashflow

The company had negative total cash flow in the most recent four quarters.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector